Imiquimod-d 7

Overview

Imiquimod-d 7 (R 837-d 7 ) is deuterium labeled Imiquimod. Imiquimod (R 837), an immune response modifier, is a selective toll like receptor 7 ( TLR7 ) agonist. Imiquimod exhibits antiviral and antitumor effects in vivo. Imiquimod can be used for the research of external genital, perianal warts, cancer and COVID-19.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > SARS-CoV | Products > Signaling Pathways > Isotope-Labeled Compounds | Products > Signaling Pathways > HSV | Products > Signaling Pathways > Autophagy | Products > Signaling Pathways > Toll-like Receptor (TLR)

Product Information

• Catalog No.: HY-B0180S2
• CAS No.: 2748349-99-5
• Molecular Formula: C14H9D7N4
• Molecular Weight: 247.35
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source